SCN1A mutations are associated with developmental and epileptic encephalopathy, Dravet syndrome, febrile seizures, and generalized epilepsy with febrile seizures plus (GEFS+) [18,19,20]. This evidence concerns the gene SCN1A and generalized epilepsy.